Blog - Page 3164 of 5443

ThursdayJul 21, 2011 6:09 pm

Nephros, Inc. (NEPH) Receives 510k Clearance to Market Their MSU And SSU Ultrafilters

Nephros, Inc. announced that they received 510k clearance from the U.S. Food and Drug Administration to market their MSU and SSU ultrafilters. These are to filter out biological contaminants from water and bicarbonate solution used in hemodialysis procedures. Dr. Paul Mieyal, Acting Chief Executive Officer of Nephros, Inc., said, "Nephros is pleased to have received clearance from the FDA to market the MSU and SSU for hemodialysis applications. The MSU and SSU represent extensions of the Nephros ultrafiltration product line and enable Nephros products to address a wider range of fluid flow requirements." The Nephros DSU, MSU, and SSU are…

ThursdayJul 21, 2011 3:14 pm

Corgenix Medical Corp. (CONX) Announces $1.5 Million Line of Credit Facility

Corgenix Medical Corp., a company that engages in the research, development, manufacture, and marketing of in vitro diagnostic products for use in disease detection and prevention in North America and internationally, recently announced that it has closed upon a $1.5 million secured revolving line of credit with LSQ Funding Group, L.C, (LSQ). The new revolving line of credit offers Corgenix a very favorable interest rate and much more flexibility than the former factoring and inventory line of credit. The initial funding is approximated at $1.1 million. This financing has enabled the retirement of Corgenix’s factoring line of credit and inventory…

ThursdayJul 21, 2011 2:11 pm

Alliqua, Inc. (ALQA) Targets $11.8 Billion Wound Care Marketplace with Acquisition of Two Exclusive Licenses from Noble Biomaterials, Inc.

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and wound care technologies, yesterday announced that it had acquired a 10 year exclusive global license from Noble Biomaterials, Inc. for two wound care dressings, with an additional 10 year renewal option. The new licenses are for a hydrocolloid with X-STATIC® and a hydrogel with X-STATIC® that utilizes Alliqua’s hydrogels. Both products have already received their 510(k) clearance from the U.S. Food and Drug Administration. Noble Biomaterials will continue to supply the X-STATIC® for the dressings and will receive royalty payments. These two…

ThursdayJul 21, 2011 1:29 pm

Intelligent Communication Enterprise Corp. (ICMC) Enters into Distribution Agreement

Intelligent Communication Enterprise (“ICE”) is a company on the rise. With offices across the globe, ICE has quickly made a name for themselves by offering a range of innovative enterprise and consumer solutions over the mobile phone. Today, ICE took a major step towards prominence with the announcement they have entered into a distribution agreement with UTV Interactive. UTV Interactive is the digital arm of UTV, India’s media and entertainment conglomerate which distributes celebrity based content overseas. The agreement will kick off the relationship between these two companies which will pave the way for UTV’s content to be distributed across…

ThursdayJul 21, 2011 1:23 pm

Willow Creek Enterprises Inc. (WLOC) Updates Drilling Program at Hercules Project

Willow Creek Enterprises Inc. issued an update on the exploration program being conducted at the company’s gold and silver mining property in the United States. Willow Creek Enterprises has completed fifteen exploratory drill holes at the Hercules Gold and Silver Property located in Lyon County, Nevada. The company has decided to increase the amount of exploratory drilling at the property. The previous program at the Hercules Gold and Silver Property called for between twelve and fourteen drill holes as part of the initial phase of the program. Willow Creek Enterprises did not specify how many additional holes will be drilled.…

ThursdayJul 21, 2011 1:15 pm

International Stem Cell (ISCO) Initiates Series of Clinical Studies of Human-derived Stem Cells

International Stem Cell Corp. yesterday announced it has launched a series of preclinical animal studies of neuronal cells derived from ISCO’s proprietary pluripotent stem cells from unfertilized eggs, with a long-term endpoint of creating a regenerative therapy for Parkinson’s disease (PD). PD is a disease afflicting the central nervous system, with some symptoms stemming from the loss of dopaminergic neurons in the mid brain. ISCO’s approach to develop cell-based therapy for the treatment of PD is first to derive neuronal cells successfully from human parthenogenetic stem cells (hpSC). The next step is to evaluate the in vivo safety, functionality and…

ThursdayJul 21, 2011 12:51 pm

Airline Intelligence Systems Inc. (ASYI) Part of a Major Shift in Airline Efficiency

Richard Branson, founder of Virgin Atlantic Airways, is famous for saying that the best way to become a millionaire in the airline business is to start off as a billionaire. There was a time when airline service, like telephone service, was strictly regulated. Prices were high, and flying was a luxury, but airline financial security was all but guaranteed. No major U.S. carrier had ever gone broke. Today, airlines ride a roller coaster of wide open competition, unpredictable fuel prices, and layers of security that were unimaginable in the early years of the jet age. The road is littered with…

ThursdayJul 21, 2011 12:45 pm

Entegris Inc. (ENTG) Posts Solid Q2 Results Despite Softening Semiconductor Industry

Entegris Inc., a provider of a range of products for the semiconductor and high-tech industries, today reported its financial results for the second quarter ended July 2, 2011. Second-quarter sales of $209.2 million represent an increase of 25 percent over the prior year. Net income was $32.5 million, or $0.24 per diluted share. On an operating basis, Entegris reported an adjusted operating margin of nearly 21 percent of sales, marking a record high for the company, which it attributes in part to improved gross margin. The company generated record cash from operations of $52 million, and ended the second quarter…

ThursdayJul 21, 2011 12:40 pm

Omni Bio Pharmaceutical, Inc. (OMBP) Purchases 25% of BioMimetix for $2 Million

Omni Bio Pharmaceutical Inc. is an emerging biopharmaceutical company that has licensed therapies currently in development that have the potential to address large, unmet diseases and generate substantial commercialization potential. The company's core strategy centers around licensing issued and pending patents that cover new uses for an existing FDA-approved drug. The company today announced that it has acquired a 25 percent equity ownership of BioMimetix Inc. for $2 million in cash. In addition to this initial stake, Omni Bio was issued a common stock purchase warrant to acquire up to an additional 15 percent equity ownership interest in BioMimetix for…

ThursdayJul 21, 2011 11:13 am

Small Cap Voice Featured Company: XZERES Corp. (XPWR)

XZERES Corp. is focused on designing, developing, manufacturing and marketing distributed generation, wind power systems for the alternative energy market. The company’s grid connected and off grid wind turbine systems are utilized for micro-grid based rural electrification, agricultural purposes, small business, rural electric utility systems, as well as other private, corporate infrastructure and government applications. The company’s product portfolio currently includes 2.5 kW and 10 kW rated power systems, with additional larger systems in development. Comprised of a wind turbine, power electronics, towers, and auxiliary components, each system provides a complete solution featuring high efficiency design with reduced service and…

Site Search

Company Search